Zoetis (WBO:ZOTS) FFO


WBO:ZOTS Zoetis Inc WBO:ZOTS
68 GF Score
Price €66.04
GF Value €166.17
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis FFO?

FFO (Funds from operations) only applies to REITs.

WBO:ZOTS
68GF Score
Zoetis Inc WBO:ZOTS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zoetis (WBO:ZOTS) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of €66.04 is trading 60.3% below its estimated GF Value™ of €166.17. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for WBO:ZOTS:

  • FFO:
  • GF Value™: €166.17 vs. price of €66.04 (60.3% below fair value)
  • GF Score™: 68/100

No single metric tells the full story. See the WBO:ZOTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
68GF Score

Get the complete analysis for WBO:ZOTS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.04
Price
€166.17
GF Value